Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9Y3A5
UPID:
SBDS_HUMAN
Alternative names:
Shwachman-Bodian-Diamond syndrome protein
Alternative UPACC:
Q9Y3A5; A8K0P4; Q96FX0; Q9NV53
Background:
The Ribosome maturation protein SBDS, also known as Shwachman-Bodian-Diamond syndrome protein, plays a crucial role in ribosome biogenesis. It is essential for the assembly of mature ribosomes, facilitating the GTP-dependent release of EIF6 from 60S pre-ribosomes, thereby activating ribosomes for translation competence. This protein is also involved in protein synthesis, cellular stress resistance, DNA damage response, and cell proliferation.
Therapeutic significance:
Given its pivotal role in ribosome biogenesis and cellular processes, the Ribosome maturation protein SBDS is closely associated with Shwachman-Diamond syndrome 1, a disorder marked by hematopoietic abnormalities, exocrine pancreatic dysfunction, and skeletal dysplasia. Understanding the role of Ribosome maturation protein SBDS could open doors to potential therapeutic strategies for this syndrome.